NBDC Research ID: hum0247.v1

 

SUMMARY

Aims: Establishment of a tumor infiltrating lymphocytes (TIL) therapy for malignant melanoma

Methods: Exome sequencing of melanoma tissues for TIL production and paired peripheral blood mononuclear cells (PBMC)

Participants/Materials: human melanoma and paired PBMC

 

Dataset IDType of DataCriteriaRelease Date
JGAS000249 NGS (Exome) Controlled-access (Type I) 2021/01/04
DRA010773 NGS (Exome) Unrestricted-access 2021/01/04

*Release Note

*Data users need to apply an application for Using NBDC Human Data to reach the Controlled-access Data. Learn more

*When the research results including the data which were downloaded from NHA/DRA, are published or presented somewhere, the data user must refer the papers which are related to the data, or include in the acknowledgment. Learn more

 

MOLECULAR DATA

JGAS000249 / DRA010773

Participants/Materials

melanoma (ICD10: C43.3, C43.7): 3 cases

    tumor tissue: 3 samples

    non-tumor tissue (PBMC): 3 samples

Targets Exome
Target Loci for Capture Methods -
Platform Illumina [HiSeq 1500]
Library Source DNAs extracted from tumor tissues and PBMCs of melanoma patients
Cell Lines -
Library Construction (kit name) SureSelect Human All Exon Kit V6
Fragmentation Methods Ultrasonic fragmentation (Covaris)
Spot Type Paired-end
Read Length (without Barcodes, Adaptors, Primers, and Linkers) 100 bp
Japanese Genotype-phenotype Archive Dataset ID / DDBJ Sequence Read Archive ID

non-tumor tissues: JGAD000349

tumor tissues: DRA010773

Total Data Volume

non-tumor tissues: 25 GB (fastq)

tumor tissues: 15 GB (bam [ref: hg19])

Comments (Policies) NBDC policy

 

DATA PROVIDER

Principal Investigator: Takashi Iwata

Affiliation: Department of Obsterics and Gynecology, Keio University School of Medicine

Project / Group Name: -

Funds / Grants (Research Project Number):

NameTitleProject Number
Practical Research for Innovative Cancer Control, Japan Agency for Medical Research and Development (AMED) Pilot study of adoptive cell therapy using cultured tumor infiltrating lymphocytes with lympho-depleting non-myeloablative preconditioning for patients with metastatic melanoma JP17ck0106158

 

PUBLICATIONS

TitleDOIDataset ID
1 Pilot study of adoptive cell therapy using cultured tumor infiltrating lymphocytes for Japanese melanoma patients refractory to immune-checkpoint inhibitors doi: 10.1111/cas.15009

JGAD000349

DRA010773

2

 

USRES (Controlled-access Data)

Principal InvestigatorAffiliationCountry/RegionResearch TitleData in Use (Dataset ID)Period of Data Use
Takuya Yamamoto Laboratory of Precision Immunology, National Institutes of Biomedical Innovation, Health and Nutrition Japan Basic research for vaccine development against gastrointestinal cancer and malignant melanoma based on the identification of novel cancer antigens JGAD000349 2024/11/12-2025/09/01